2012European Journal of Cancer PreventionRequires access

Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans

Chunmeng Wang, Zhiguo Luo, Biqing Zheng, Yong Chen, Xi Cao, Jian Wang, Ruming Zhang, Yingqiang Shi

Open publisher page 2 citations

Abstract

Wang, Chunmenga; Luo, Zhiguob; Zheng, Biqinga; Chen, Yonga; Cao, Xia; Wang, Jianc; Zhang, Ruminga; Shi, Yingqianga Author Information

About this research paper

What this paper is about

Wang, Chunmenga; Luo, Zhiguob; Zheng, Biqinga; Chen, Yonga; Cao, Xia; Wang, Jianc; Zhang, Ruminga; Shi, Yingqianga Author Information

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Wang, Chunmenga; Luo, Zhiguob; Zheng, Biqinga; Chen, Yonga; Cao, Xia; Wang, Jianc; Zhang, Ruminga; Shi, Yingqianga Author Information

Key concepts: Dermatofibrosarcoma protuberans, Imatinib mesylate, Medicine, Imatinib, Dermatofibrosarcoma, Oncology, Internal medicine, Dermatology

Related papers

Back to paper searchBrowse research topicsOriginal source
Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans — Research Paper | ScholarLens